Recent meta-analyses support this by demonstrating that microbiota-derived interventions significantly improve serum levels of fasting insulin and hemoglobin A1c, both of which are key markers of disease progression in T2DM patients [4]. Here, INS is linked to type 2 diabetes mellitus.